Robert Allan Zivin

Title: The Innovations of Robert Allan Zivin

Introduction

Robert Allan Zivin is a notable inventor based in Lawrenceville, NJ (US). He has made significant contributions to the field of biomedical research, particularly in the development of antibodies for therapeutic use. With a total of 9 patents to his name, Zivin's work has had a profound impact on the treatment of thrombotic diseases.

Latest Patents

One of Zivin's latest patents is focused on CDR-grafted anti-tissue factor antibodies and methods of use thereof. This invention provides CDR-grafted antibodies against human tissue factor that retain the high binding affinity of rodent monoclonal antibodies against tissue factor but have reduced immunogenicity. The humanized antibodies developed through this invention are potent anticoagulants, making them useful in the treatment and prophylaxis of human thrombotic disease. Additionally, the invention outlines methods for creating these antibodies and pharmaceutical compositions aimed at the attenuation or prevention of coagulation.

Career Highlights

Throughout his career, Zivin has worked with various companies, including Centocor, Inc. His innovative research and development efforts have contributed to advancements in medical treatments and therapies.

Collaborations

Zivin has collaborated with several professionals in his field, including Linda K. Jolliffe. These collaborations have further enhanced the scope and impact of his research.

Conclusion

Robert Allan Zivin's contributions to the field of biomedical research, particularly through his innovative patents, have established him as a key figure in the development of therapeutic antibodies. His work continues to influence the treatment of thrombotic diseases and showcases the importance of innovation in medicine.